Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess whether TAB08 may be beneficial compared to placebo in patients with active Systemic Lupus Erythematosus, not adequately controlled with current concomitant trea...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Theramab LLC
NCT07330245 · Lupus Erythematosus, Systemic
NCT07015983 · Lupus Erythematosus, Systemic, Lupus Nephritis
NCT07438496 · Lupus Erythematosus, Systemic
NCT06673043 · Lupus Erythematosus, Systemic
NCT05648500 · Lupus Erythematosus, Systemic
Federal State Budget Institution "Research Institute of Rheumatology of V.A. Nasonova" Russian Academy of Medical Sciences
Moscow
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions